Dan Schell articles

  1. 4 Questions About A Digital Therapeutic Clinical Trial 4/8/2024

    Tim Peters-Strickland, SVP, clinical development & medical affairs at Click Therapeutics, explains some of the details that went into the recently FDA-approved Rejoyn digital therapeutic, which was a joint collaboration between Otsuka and Click.

  2. Dear Data Analysts, AI Is Not Replacing You 4/2/2024

    Deep beneath the ongoing narrative of AI’s potential use cases in clinical trials is the same fear that persists in other industries facing a technology revolution. Will jobs be lost and replaced by machines? So, I thought I’d ask an expert — a machine.

  3. Why Jane Myles Believes DCTs Are "Completely Doable" 3/27/2024

    If you want to know about how perceptions regarding DCTs are changing, talk with Jane Myles of the DTRA (Decentralized Trials & Research Alliance). As Program Director at DTRA, she is acutely aware of all the challenges and opportunities surrounding anything with the term “decentralized trial.”

  4. How Takeda Leverages Cultural Competency Training To Improve Diversity 3/14/2024

    Karen Correa, VP, head global clinical operations at Takeda, details some uncommon ways the pharma is tackling the problem of diversity in clinical trials. 

  5. Do ClinOps Professionals Understand The CAR-T Supply Chain? 3/4/2024

    Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials. 

  6. Ramblings From A First-Time SCOPE Attendee 2/15/2024

    Dan Schell, chief editor of Clinical Leader, discusses what sessions stood out to him and some of the KOLs he rubbed elbows with while attending his first SCOPE Summit. 

  7. No Surprise: Patient Recruitment Still Sucks 2/14/2024

    Patient recruitment expert Ross Jackson talks about why this part of the clinical trials ecosystem is still a problem and offers up some solutions, specifically around digital/social media outreach.

  8. A Tribe Called SOS 2/5/2024

    A first-hand account of a first-time industry conference. Dan Schell, chief editor of Clinical Leader, talks about his impressions of the Save Our Sites (SOS) conference that happened in Tucson, AZ on Feb. 2, 2024.

  9. It's Hard To Predict AI's Real Value To Clinical Trials 2/1/2024

    Sunny Kumar, a partner at GSR Ventures, plans to talk about AI and ML use in clinical trials during the SCOPE Summit panel, “The Future of Clinical Trial Tech: Perspectives from Different Investors.”

  10. The Impact Of Protocol Design On An IRT System 1/31/2024

    DTP and home treatment studies can get expensive — and be a hassle to patients — if the IRT element isn’t well planned for during trial design. In their SCOPE Summit presentation, Irina Grishina and Kelsey Kern of CSL Behring plan to share their personal anecdotes and lessons learned from both types of trials as they pertain to IRT.